Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBVAXPRO Challenge Dose in Children Primed with Hexavac or Infanrix Hexa
NCT02012998Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jan 2014
- Primary completion
- Feb 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Recombivax HB in hepatitis B (HBV), sponsored by Sanofi. Started Jan 2014; status: completed.
02
Drugs
Recombivax HB
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT02012998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02012998.